Phibro Animal Health (PAHC) Stock Overview
Operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 4/6 |
PAHC Community Fair Values
Create NarrativeSee what 12 others think this stock is worth. Follow their fair value or set your own to get alerts.
Phibro Animal Health Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$36.39 |
| 52 Week High | US$41.57 |
| 52 Week Low | US$16.16 |
| Beta | 0.82 |
| 1 Month Change | -8.15% |
| 3 Month Change | 19.08% |
| 1 Year Change | 49.81% |
| 3 Year Change | 159.56% |
| 5 Year Change | 103.87% |
| Change since IPO | 114.06% |
Recent News & Updates
Phibro Animal Health: Zoetis Growth, Valuation Still Attractive
Sep 02Phibro Animal Health Corporation's (NASDAQ:PAHC) Shares Bounce 37% But Its Business Still Trails The Industry
Aug 29
Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12
Aug 21Recent updates
Phibro Animal Health: Zoetis Growth, Valuation Still Attractive
Sep 02Phibro Animal Health Corporation's (NASDAQ:PAHC) Shares Bounce 37% But Its Business Still Trails The Industry
Aug 29Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12
Aug 21Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12
Aug 02Phibro Animal Health (NASDAQ:PAHC) Takes On Some Risk With Its Use Of Debt
Jul 02Statutory Profit Doesn't Reflect How Good Phibro Animal Health's (NASDAQ:PAHC) Earnings Are
May 15Phibro Animal Health Corporation Just Recorded A 11% EPS Beat: Here's What Analysts Are Forecasting Next
May 10Phibro Animal Health Is Cruising With Its Recent Zoetis Acquisition
Feb 13Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12
Feb 08Phibro Animal Health Corporation's (NASDAQ:PAHC) Popularity With Investors Is Clear
Jan 28Phibro Animal Health (NASDAQ:PAHC) Is Paying Out A Dividend Of $0.12
Nov 25There May Be Reason For Hope In Phibro Animal Health's (NASDAQ:PAHC) Disappointing Earnings
Nov 13
Rising Costs And Currency Risks Mar Outlook, Yet Calculated Acquisitions And Initiatives Promise Growth
Increased SG&A expenses and elevated capital expenditures risk diluting net margins and EPS, impacting overall financial performance.Phibro Animal Health Corporation's (NASDAQ:PAHC) Shares Bounce 26% But Its Business Still Trails The Industry
Sep 14Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12
Aug 29Phibro Animal Health (NASDAQ:PAHC) Will Pay A Dividend Of $0.12
Aug 15New Forecasts: Here's What Analysts Think The Future Holds For Phibro Animal Health Corporation (NASDAQ:PAHC)
May 14Phibro Animal Health (NASDAQ:PAHC) Is Paying Out A Dividend Of $0.12
May 11Phibro Animal Health: An Interesting Deal With Zoetis For A Struggling Business
May 01Market Participants Recognise Phibro Animal Health Corporation's (NASDAQ:PAHC) Earnings Pushing Shares 30% Higher
Apr 30Phibro Animal Health (NASDAQ:PAHC) Is Due To Pay A Dividend Of $0.12
Feb 10Phibro Animal Health (NASDAQ:PAHC) Use Of Debt Could Be Considered Risky
Dec 06Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12
Nov 10A Look At The Fair Value Of Phibro Animal Health Corporation (NASDAQ:PAHC)
Nov 05Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12
Aug 28Phibro Animal Health (NASDAQ:PAHC) Is Paying Out A Dividend Of $0.12
Jul 29Phibro Animal Health (NASDAQ:PAHC) Is Due To Pay A Dividend Of $0.12
Feb 10Shareholder Returns
| PAHC | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -3.7% | -1.6% | -2.7% |
| 1Y | 49.8% | -6.1% | 13.4% |
Return vs Industry: PAHC exceeded the US Pharmaceuticals industry which returned -6.1% over the past year.
Return vs Market: PAHC exceeded the US Market which returned 13.4% over the past year.
Price Volatility
| PAHC volatility | |
|---|---|
| PAHC Average Weekly Movement | 7.5% |
| Pharmaceuticals Industry Average Movement | 9.2% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 17.3% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PAHC has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: PAHC's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1946 | 2,475 | Jack Bendheim | www.pahc.com |
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Phibro Animal Health Corporation Fundamentals Summary
| PAHC fundamental statistics | |
|---|---|
| Market cap | US$1.48b |
| Earnings (TTM) | US$48.26m |
| Revenue (TTM) | US$1.30b |
Is PAHC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PAHC income statement (TTM) | |
|---|---|
| Revenue | US$1.30b |
| Cost of Revenue | US$890.59m |
| Gross Profit | US$405.62m |
| Other Expenses | US$357.36m |
| Earnings | US$48.26m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.19 |
| Gross Margin | 31.29% |
| Net Profit Margin | 3.72% |
| Debt/Equity Ratio | 254.8% |
How did PAHC perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/13 19:41 |
| End of Day Share Price | 2025/10/10 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Phibro Animal Health Corporation is covered by 15 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Matthew Korn | Barclays |
| Douglas Tsao | Barclays |
| Balaji Prasad | Barclays |